How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations? Podcast Por arte de portada

How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations?

How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations?

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Maternal RSV vaccines and infant nirsevimab led to major drops in hospitalizations among infants ≤7 months, especially those ≤2 months old. The CDC’s 2025 nPEP guidelines stress starting HIV prevention within 72 hours of exposure, with rapid testing and follow-up care. Treatment should begin without delay, and patients at ongoing risk should transition to PrEP. Surgical site infections after colorectal surgery have increased 21% since 2019, highlighting the need to strengthen infection control.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones